Lupin launches Tadalafil Tablets USP
April 02, 2019 | Tuesday | News
It is the generic equivalent of Eli Lilly and Company’s Cialis Tablets
Lupin has announced the launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin’s Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, is the generic equivalent of Eli Lilly and Company’s Cialis Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. It is indicated for the treatment of:
- erectile dysfunction (ED)
- the signs and symptoms of benign prostatic hyperplasia (BPH)
- ED and the signs and symptoms of BPH (ED/BPH)
Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg (RLD: Cialis) had annual sales of approximately USD 1780 million in the US (IQVIA MAT December 2018).
